Doctor profile · Federal record
Dr. Patrick Retterbush, M.D.
Mohs-Micrographic Surgery Physician (CMS: Dermatology) · Dermatology Physician · Athens, GA
- NPI 1700176211
- Accepts Medicare
- MIPS 97.3 / 100 · 2023
- 15 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1500 Oglethorpe Ave Ste 300A
Athens, GA 306062181
(706) 614-1750
fax (706) 480-4185
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- May 28, 2019
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207ND0101X — NUCC code
- State license (1)
- Georgia #73445
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1700176211. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,867
Distinct HCPCS
10
Medicare allowed
$586,837
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 4,600 | 14 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,826 | 286 | $6 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 518 | 349 | $121 | |
17000 |
Destruction of precancer skin growth, 1 growth | 517 | 364 | $42 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 364 | 291 | $85 | |
11102 |
Biopsy of related skin growth, first growth | 333 | 278 | $73 | |
17110 |
Destruction of skin growth, 1-14 growths | 322 | 263 | $101 | |
17311 |
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 267 | 195 | $472 | |
11103 |
Biopsy of related skin growth, each additional growth | 133 | 87 | $45 | |
13132 |
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 115 | 103 | $241 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 290. This provider delivers 34× the peer median.Open Payments
Industry payments received
All-time total
$823
Transactions
30
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 8 | $264.00 | |
| ABBVIE INC. | 10 | $224.25 | |
| GENZYME CORPORATION | 3 | $113.39 | |
| Amgen Inc. | 2 | $63.21 | |
| Novartis Pharmaceuticals Corporation | 3 | $56.44 | |
| Almirall LLC | 1 | $40.12 | |
| PFIZER INC. | 1 | $24.76 | |
| Dermavant Sciences, Inc. | 1 | $19.44 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16.91 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,243
Patients
814
Total drug cost
$48,260
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 242 | 114 | $5,293 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 176 | 151 | $557 |
| Clobetasol Propionate | Generic | 159 | 98 | $12,364 |
| Doxycycline Hyclate | Generic | 153 | 106 | $2,934 |
| Mupirocin | Generic | 91 | 75 | $783 |
| Fluorouracil | Generic | 80 | 65 | $7,841 |
| Clindamycin Phosphate | Generic | 69 | 37 | $6,700 |
| Fluocinolone Acetonide | Generic | 59 | 39 | $4,299 |
| Metronidazole | Generic | 43 | 31 | $3,408 |
| Triamcinolone Acetonide | Generic | 42 | 30 | $899 |
Frequently asked questions
What is Dr. Patrick Retterbush's medical specialty?
Dr. Patrick Retterbush practices Mohs-Micrographic Surgery Physician in Athens, GA.
Where does Dr. Patrick Retterbush practice?
Dr. Patrick Retterbush practices at 1500 Oglethorpe Ave Ste 300A, Athens, GA 306062181. Office phone: 7066141750.
What is Dr. Patrick Retterbush's NPI?
Dr. Patrick Retterbush's National Provider Identifier (NPI) is 1700176211, issued by NPPES.
Does Dr. Patrick Retterbush accept Medicare assignment?
Yes. Dr. Patrick Retterbush accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Patrick Retterbush commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.